Teradyne, Inc.

NASDAQ Global Select
Back to all articles
Somewhat Bullish +45

Teradyne Stock Is Up Around 140% in 2026. Cantor Just Put a $550 Target on It, So Why Is the Street Still at $399? - TIKR.com

📈 Cantor Fitzgerald raised its price target to $550 and Bank of America to $525, both maintaining bullish ratings despite the stock trading above the Street's mean target of ~$400.

🧠 CEO Gregory Smith forecasts the semiconductor test equipment market could expand from $9 billion in 2025 to $12-14 billion by 2030 driven by AI and HBM demand.

📊 Teradyne reported record Q1 2026 revenue of $1.282 billion (up 87% YoY) and non-GAAP EPS of $2.56, though Q2 guidance shows a sequential decline.

💰 The company trades at a premium 49x NTM EV/EBITDA compared to peers like Advantest (32x) and Applied Materials (40x), raising valuation concerns.

🔍 Bulls argue that increased wafer production and HBM complexity will drive Teradyne's market share from 30% toward 38% in the compute and DRAM segments.

⚠️ The stock dropped 19.41% immediately after a record earnings beat, indicating investors are pricing in high expectations for future order visibility.

📅 Teradyne joined the Nasdaq-100 on June 22, forcing passive fund inflows that contributed to the recent price rally independent of fundamentals.

🎯 The mid-case valuation model suggests a potential ~125% total return over ~4.5 years if the company captures the projected CAGR through 2030.

📉 A conservative consensus model implies a downside target of around $390, highlighting the wide gap between bullish and bearish analyst views.

🔑 The July 28, 2026 Q2 earnings report will be pivotal for confirming whether HBM orders are actually building in the backlog to justify the high multiple.

Bullish Signals
  • Cantor Fitzgerald and Bank of America raised price targets to $550 and $525 respectively, signaling strong institutional confidence in Teradyne's long-term growth potential.
  • Teradyne achieved record Q1 2026 revenue of $1.282 billion and non-GAAP EPS of $2.56, demonstrating robust top-line performance despite sector headwinds.
  • CEO Gregory Smith projects the automated test equipment market could double to $12-14 billion by 2030, driven by AI accelerators and HBM adoption.
  • The company is gaining market share in compute and DRAM testing segments as it transitions from a weaker position held since 2021.
  • Teradyne's net income margin is expected to improve toward 28% as its mix shifts toward higher-value semiconductor test services.
Risk Factors
  • The stock trades at a significant premium with a 49x NTM EV/EBITDA multiple, well above peers like Advantest (32x) and Applied Materials (40x).
  • Management provided limited visibility into the back half of the year, with Q2 revenue guidance below the record Q1 actuals.
  • The stock dropped nearly 20% immediately after a record earnings beat, suggesting investors fear the premium valuation is not fully justified by current fundamentals.
  • Customer concentration remains a primary risk, where a single program delay could negatively impact estimates and the stock price simultaneously.
  • Analysts warn that if AI capital spending digests faster than expected, the conservative valuation model suggests a downside target of around $390.
Full Analysis
Teradyne (TER) shares closed at $463.21 on June 29, 2026, following bullish price target raises from Cantor Fitzgerald ($550) and Bank of America ($525), which significantly outpace the Street's mean target of roughly $400. This divergence highlights a split in analyst sentiment regarding the company's valuation and future growth trajectory within the semiconductor testing sector. The bullish thesis relies on Teradyne capturing a growing market for high-bandwidth memory (HBM) testing, driven by AI infrastructure buildouts. CEO Gregory Smith projects the automated test equipment market could reach $12-14 billion, with Teradyne aiming to grow its revenue share from 30% to 38%, potentially doubling its size to become a $6 billion company by leveraging increased wafer production. Despite record Q1 2026 results with revenue of $1.282 billion and non-GAAP EPS of $2.56, the stock faces skepticism due to limited visibility into the back half of the year and a premium valuation trading at 49x NTM EV/EBITDA compared to peers like Advantest (32x) and Applied Materials (40x). The market recently punished this premium with a nearly 20% drop after earnings, suggesting investors are wary of whether anticipated orders will materialize. The critical test for Teradyne arrives on July 28, 2026, when it reports Q2 results. Investors will be watching to see if management can confirm that memory and HBM orders are building in the backlog while maintaining or raising full-year targets. Failure to do so could trigger a reversal of the recent rally as the premium multiple compresses amid concerns about customer concentration and potential AI capital spending digestion.